Re: Several Questions

From: Robert Johnson (johnson@caltag.com)
Date: Thu Dec 14 2000 - 10:50:56 EST


Dear Melanie

Caltag's Fix & Perm is a stand alone system.  If you have already done any
previous lysing, you cannot use Fix & Perm as a an additional step.  This will
be clear in the scatter pattern which will not be normal.
Regards
Bob Johnson
Caltag

"O'Donahue, Melanie ." wrote:

> Charles,
> I have begun doing cytoplasmic staining on CLL patients that do not exhibit
> surface light chains. I use the stained and fixed tube, assuming there is
> enough left after acquisition. I add 100 ul reagent B from Caltag's fix and
> perm and more light chain antibody and incubate for 15 minutes. Then I wash
> in PBS, resuspend, and acquire again. Quite often the light chains appear!
> Thanks for the CD 38 reference. I'll definitely read that.
> Melanie O'Donahue
> Mayo Clinic Scottsdale
>
> -----Original Message-----
> From: Repetti, Charles [mailto:crepetti@aml.com]
> Sent: Monday, December 11, 2000 12:59 PM
> To: cyto-inbox
> Subject: RE: Several Questions
>
> Melanie;
> The CD38 references are in Blood, Sept 15, 1999Vol 94,pp1837-1839;
> pp1840-1847 (the flow CD38); pp 1848-1854. CD5-FITC, CD38-PE, CD19-PE:CY5.
> The CD38 is usually discreet, almost all negative or mostly positive in the
> 2nd or 3rd decade.
>
> CLLs without K,L: have very little experience with intracellular, would
> recommend intsead having alternative k,l clones for surface staining.  Would
> be interested in any info on cytoplasmic stains.
>
> good luck
> Charles
>
> -----Original Message-----
> From: O'Donahue, Melanie . [mailto:ODonahue.Melanie@MAYO.EDU]
> Sent: Friday, December 08, 2000 4:36 PM
> To: cyto-inbox
> Subject: Several Questions
>
> Hello all,
> There are several things I'm trying to troubleshoot and/or improve and I
> would appreciate any input from my fellow flowers.
> Are any of you doing platelet hyper aggregation studies with flow?
> Also, have you had any experience running CD 38 on CLL patients? It's
> supposed to be a prognostic indicator. One of our heme onc docs is
> interested in it.
> On CLL patients that don't express light chains, do you routinely run them
> intracellularly? What rate of success do you have with that?
> Final question. Do you run your light chains in two separate tubes? Is their
> a reason for that? We are having problems with our three color
> (kappa-lambda-CD 19) tube and I'm wondering if I should be running two color
> instead.
> Thanks for any input. Have a great weekend!
> Melanie O'Donahue, MT, ASCP
> Mayo Clinic Scottsdale



This archive was generated by hypermail 2b29 : Sat Mar 10 2001 - 19:31:41 EST